SAB Biotherapeutics Inc Common is a security (CUSIP 78397T202) tracked across SEC portfolio filings. 80 institutional managers reported $252.0M on Form 13F as of 2026-06-30; 4 registered fund positions totaling $1.6M via N-PORT as of 2026-03-31.
Showing 15 of 80 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Vivo Capital, LLC | Palo Alto, CA | $43.7M | 11,420,000 |
| Caligan Partners LP | New York, NY | $30.5M | 7,967,207 |
| PERCEPTIVE ADVISORS LLC | NEW YORK, NY | $24.6M | 6,431,743 |
| RA CAPITAL MANAGEMENT, L.P. | Boston, MA | $16.9M | 4,401,500 |
| COMMODORE CAPITAL LP | NEW YORK, NY | $16.9M | 4,401,500 |
| Balyasny Asset Management L.P. | Chicago, IL | $14.4M | 3,760,439 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Boston, MA | $13.0M | 3,405,553 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $11.6M | 3,032,697 |
| Woodline Partners LP | San Francisco, CA | $10.9M | 2,851,791 |
| Spruce Street Capital LP | NEW YORK, NY | $8.4M | 2,198,502 |
| Sessa Capital IM, L.P. | NEW YORK, NY | $8.4M | 2,198,457 |
| VANGUARD GROUP INC | Valley Forge, PA | $6.9M | 1,847,136 |
| BOOTHBAY FUND MANAGEMENT, LLC | NEW YORK, NY | $5.7M | 1,481,660 |
| Ensign Peak Advisors, Inc | SALT LAKE CITY, UT | $5.3M | 1,375,610 |
| Soleus Capital Management, L.P. | GREENWICH, CT | $4.0M | 1,050,000 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $1.2M | 0.14% |
| Blackstone Alternative Multi-Strategy Fund | Blackstone Alternative Investment Funds | $149K | 0.41% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $144K | 0.02% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $107K | 0.04% |